<DOC>
	<DOCNO>NCT01226966</DOCNO>
	<brief_summary>This observational study conduct Europe . The aim non-interventional ( observational ) study evaluate efficacy liraglutide ( Victoza® ) ass condition use Victoza® daily medical practice France .</brief_summary>
	<brief_title>Observational Study Efficacy Safety Liraglutide Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Patients diagnose type 2 diabetes Patients recently start ( less one week ) start liraglutide ( Victoza® ) treatment Hypersensitivity ( allergy ) liraglutide excipients Patient participate clinical trial inclusion Type 1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>